Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1998
12/15/1998US5849305 Construction of Pasteurella haemolytica vaccines
12/15/1998US5849304 Recombinant vaccinia virus expressing human retrovirus gene
12/15/1998US5849303 Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
12/15/1998US5849299 Attenuated revertant serotype 1 marek's disease vaccine
12/15/1998US5849298 Treatment of multiple sclerosis by oral administration of bovine myelin
12/15/1998US5849297 Modified human C3 proteins
12/15/1998US5849295 Nucleotide sequences coding for a protein with urease activity
12/15/1998US5849293 Use of human transferrin in controlling insulin levels
12/15/1998US5849290 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
12/15/1998US5849287 Gene therapy using stromal cells
12/15/1998US5849283 Human interleukin-6 receptor antagonists
12/15/1998US5849261 Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
12/15/1998US5849260 Technetium-99M labeled peptides for thrombus imaging
12/15/1998CA2157388C Analogs for specific oligosaccharide-protein interactions and uses thereof
12/15/1998CA2152541C Herpes ribonucleotide reductase inhibitors
12/15/1998CA2144513C Morphogen-induced periodontal tissue regeneration
12/15/1998CA2118510C Measles virus-specific antibody detection using recombinant measles proteins
12/15/1998CA2092115C Testing for infestation of rapeseed and other cruciferae by the fungus leptosphaeria maculans (blackleg infestation)
12/15/1998CA2091886C Multiple promoter baculovirus expression system and defective particle production
12/15/1998CA1340269C Homogeneous dimeric m-csf and storage stable formulations thereof
12/15/1998CA1340266C Human pluripotent hematopoietic colony stimulating factor, method of production and use
12/15/1998CA1340265C Oxidation resistant muteins
12/15/1998CA1340264C Recombinant dna expression of novel diuretic/vasodilator compounds
12/15/1998CA1340251C Plants transformed with a dna sequence from bacillus thuringiensis lethal to lepidoptera
12/15/1998CA1340245C Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same
12/15/1998CA1340244C Dnas and processes for their preparation, novel plasmids comprising themnovel polypeptides and processes for their preparation and novel anti-tumor agents comprising said polypeptides
12/15/1998CA1340243C Recombinant marek's disease virus and a vaccine
12/15/1998CA1340237C Process for isolating basic proteins from protein mixtures containing such basic proteins
12/15/1998CA1340236C Method of preparing highly purified alpha-1-proteinage inhibitor
12/15/1998CA1340233C Antigenic epitopes of immunoglobulin e present on b cell but not basophil surface
12/15/1998CA1340232C Dna sequence, recombinant dna molecules and processes for producing lymphocyte function associated antegen-3
12/15/1998CA1340222C Preparations of placenta collagen, their extraction method and their applications
12/15/1998CA1340221C Vectors, compounds and method for expression of a human adenocarcinoma antigen
12/15/1998CA1340217C Process for the isolation and preparation of pasteurized alpha2-antiplasmin product
12/15/1998CA1340213C Antigens of plasmodium falciparum
12/15/1998CA1340212C Expression of biologically active platelet derived growth factor analogsin eucaryotic cells
12/15/1998CA1340203C Recombinant apivoxvirus
12/15/1998CA1340202C Method to control leukocyte extravasation
12/15/1998CA1340201C Receptors for immune complexes
12/15/1998CA1340197C Hirudin derivatives with delayed action
12/15/1998CA1340196C Immunodiagnostic method for neurocysticercosis
12/15/1998CA1340187C Peptides that inhibit von willebrand factor binding
12/15/1998CA1340186C Peptides
12/15/1998CA1340184C Cloning and characterizing omega-interferon and related genes
12/15/1998CA1340183C Immunologically active whey fraction and recovery process
12/15/1998CA1340182C Method for detecting cellular pathology
12/13/1998CA2234424A1 Novel compounds
12/11/1998CA2233584A1 7tm receptor hlwar77
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055873A2 Use of a fluorescent protein for detecting interaction between a target protein and its ligand
12/10/1998WO1998055855A1 Improved biosensor involving the use of optically sensitive moieties
12/10/1998WO1998055656A1 Reagents and methods useful for detecting diseases of the urinary tract
12/10/1998WO1998055649A1 Nucleic acid probes for the detection and identification of fungi
12/10/1998WO1998055643A1 Human adamts-1 protein, gene coding for the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein
12/10/1998WO1998055641A2 Somatic gene therapy to suppress secondary cataract formation
12/10/1998WO1998055639A2 Recombinant adenoviral vectors comprising a splicing sequence
12/10/1998WO1998055638A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/10/1998WO1998055635A1 Methods of assaying receptor activity and constructs useful in such methods
12/10/1998WO1998055627A1 Mutant measles virus antigens and genes encoding the same
12/10/1998WO1998055626A2 Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
12/10/1998WO1998055625A1 Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants
12/10/1998WO1998055624A1 Bacterial pheromones and uses therefor
12/10/1998WO1998055623A1 Type-1 ribosome-inactivating protein
12/10/1998WO1998055622A1 Preparation of glycosylated tumor necrosis factor
12/10/1998WO1998055621A1 Ntn-2 member of tnf ligand family
12/10/1998WO1998055620A1 Ntn-2 member of tnf ligand family
12/10/1998WO1998055618A1 Mitofusin genes and their uses
12/10/1998WO1998055617A1 Translational regulator initiation factor 4e-binding protein
12/10/1998WO1998055616A2 Brca2 locus-associated protein
12/10/1998WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
12/10/1998WO1998055614A2 Secreted proteins and polynucleotides encoding them
12/10/1998WO1998055613A1 Zinc ring protein
12/10/1998WO1998055611A1 Neuregulin response element and uses therefor
12/10/1998WO1998055609A1 Inhibitors of dna immunostimulatory sequence activity
12/10/1998WO1998055607A2 Tumor targeted vector
12/10/1998WO1998055606A2 Lactoferrin receptor genes of moraxella
12/10/1998WO1998055598A1 A METHOD OF INHIBITING CANCER CELL GROWTH USING A VECTOR EXPRESSING pRb2/p130
12/10/1998WO1998055512A2 Smad-interacting polypeptides and their use
12/10/1998WO1998055511A1 Novel canine cytokine protein
12/10/1998WO1998055510A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998WO1998055509A2 Two human dnaj-like proteins
12/10/1998WO1998055508A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
12/10/1998WO1998055507A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998WO1998055506A2 Thrombin-inhibiting peptide
12/10/1998WO1998055500A1 Chemically modified polypeptides
12/10/1998WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
12/10/1998WO1998055151A1 Box-dependent myc-interacting protein (bin1) compositions and uses therefor
12/10/1998WO1998055146A1 IDENTIFICATION OF HUMAN HEAVY CHAIN ANTIBODY FRAGMENT DIRECTED AGAINST HUMAN PLATELET ALLOANTIGEN 1a(HPA-1a)
12/10/1998WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998WO1998055143A1 Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
12/10/1998WO1998055137A1 Bone morphogenetic proteins and their use in bone growth
12/10/1998WO1998055136A1 Fsh-releasing peptides
12/10/1998WO1998055133A1 A melanoma associated antigen, t cell epitopes thereof and methods of using same
12/10/1998WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998WO1998054963A2 207 human secreted proteins
12/10/1998WO1998054961A2 Plant transformation methods
12/10/1998WO1998047343A3 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
12/10/1998WO1998041188A3 Stable particle in liquid formulations
12/10/1998WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
12/10/1998WO1998039429A3 Compositions for treatment of disorders involving programmed cell death
1 ... 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 ... 2916